Randomized Trial of Tibial Nerve Stimulation Versus Pelvic Floor Exercises for Treatment of Overactive Bladder
1 other identifier
interventional
30
1 country
1
Brief Summary
Urinary incontinence is defined according to the International Continence Society as any involuntary loss of urine, which may bring several negative consequences on women's lives, and among incontinent women, about 50% have urinary incontinence, 30% mixed and 20% emergency. The overactive bladder present in urge incontinence and mixed cause significant impacts on people's lives and has a prevalence of 16.5% in the US population. Behavioral therapies, exercises the pelvic muscles and drugs are the main forms of treatment. Drug therapy using drugs which are not specific for the bladder and are associated with many unwanted systemic side effects. The results obtained by researchers in several countries using conservative techniques in the treatment of patients with urinary incontinence are encouraging and this study aims to evaluate carefully and systematically the effectiveness of tibial stimulation technique. Importantly, also, that conservative techniques have lower cost than the surgical treatment and have virtually no side effects as most of the drugs used in the pharmacological treatment of female urinary incontinence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 8, 2015
CompletedFirst Posted
Study publicly available on registry
May 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedMay 22, 2015
May 1, 2015
1.5 years
April 8, 2015
May 21, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with Urinary incontinence
3 months
Study Arms (2)
"Tibial Nerve Stimulation"
ACTIVE COMPARATORThis group will do transcutaneous electrical stimulation of the tibial nerve at home. Development of an innovative portable equipment, with domestic technology for home application of the posterior tibial nerve stimulation technique using the type SSP surface electrodes (Silver Spike Point). Frequency: 20 Hz, Pulse width: 200 us; duration: 15min daily
"Pelvic Floor Exercises"
ACTIVE COMPARATORThis group will make pelvic muscle training 3 times a day . In decubit dorsal posture, legs flexed and abductee. Perform pelvic floor contractions keeping 2 seconds and relaxing 4 seconds for 10 times, and contractions keeping 4 seconds and relaxing 8 seconds for 10 times.
Interventions
A group will make tibial nerve stimulation and the other will make pelvic floor training. After 8 weeks the patients exchanges their therapeutic approaches for over 8 weeks
Eligibility Criteria
You may qualify if:
- \- Women with Urinary Incontinence of Urgency or Mixed older than 18 years
You may not qualify if:
- Presence Of vaginal or urinary infection
- Not understand or sign the informed consent
- Not understand or are unable to perform the proposed treatment
- Pregnancy or the postpartum period covering the period up to 6 months after delivery
- Women in previous use of chronically used drugs (antidepressants, diuretics, and others) that can evidently alter the urinary function.
- Stress Urinary Incontinence of pure or mixed incontinence with a predominance of Stress component neurogenic bladder
- Use of Botox® in the bladder or pelvic muscles in the last year
- Use Interstim® or Bion®
- Use pacemaker or implantable defibrillator
- Current use of TENS in the pelvic region, lower back or legs
- Previous use of percutaneous tibial stimulation
- Drug / experimental devices in the past 4 weeks,
- Participation in any clinical research involving or affecting the urinary or renal function in the last 4 weeks.
- Pelvic radiotherapy;
- Changes in sensibility Lower Limb;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose Geraldo Dr Ramos, PhD
Federal University of Rio Grande do Sul
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
April 8, 2015
First Posted
May 22, 2015
Study Start
January 1, 2014
Primary Completion
July 1, 2015
Study Completion
August 1, 2015
Last Updated
May 22, 2015
Record last verified: 2015-05